Mealey's Litigation Procedure - Forest Settles Celexa/Lexapro Missouri Refund Class For $7.6M To $10.3M

Mealey's Litigation Procedure - Forest Settles Celexa/Lexapro Missouri Refund Class For $7.6M To $10.3M

BOSTON - Forest Laboratories Inc. has dropped its appeal of a Missouri consumer refund class certification for the antidepressant drugs Celexa and Lexapro and agreed to a settlement worth $7.65 million to $10.35 million, plaintiffs say in a brief filed March 12 in the Massachusetts multidistrict litigation court overseeing the litigation (In Re: Celexa and Lexapro Marketing and Sales Practices Litigation, MDL Docket No. 2067, No. 1:09-md-2067, D. Mass.).

Find full version on lexis Advance®
Access this news story on lexis.com®